Trial · NCT03668236
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| 90-day Mortality | Fluid Restriction Group | 323 | Participants | ||
| 90-day Mortality | Standard-care | 329 | Participants | ||
| Number of Participants With One or More Serious Adverse Events (SAEs) in the ICU | Fluid Restriction Group | 221 | Participants | ||
| Number of Participants With One or More Serious Adverse Events (SAEs) in the ICU | Standard-care | 238 | Participants | ||
| Number of Participants With One or More Serious Adverse Reactions (SARs) to IV Crystalloids in the ICU. | Fluid Restriction Group | 31 | Participants | ||
| Number of Participants With One or More Serious Adverse Reactions (SARs) to IV Crystalloids in the ICU. | Standard-care | 32 | Participants | ||
| Days Alive at Day 90 Without Life Support (Vasopressor / Inotropic Support, Invasive Mechanical Ventilation or Renal Replacement Therapy) | Fluid Restriction Group | 77 | Inter-Quartile Range 1 to 87 | days | |
| Days Alive at Day 90 Without Life Support (Vasopressor / Inotropic Support, Invasive Mechanical Ventilation or Renal Replacement Therapy) | Standard-care | 77 | Inter-Quartile Range 1 to 87 | days | |
| Days Alive and Out of Hospital at Day 90 | Fluid Restriction Group | 21 | Inter-Quartile Range 0 to 69 | days | |
| Days Alive and Out of Hospital at Day 90 | Standard-care | 33 | Inter-Quartile Range 0 to 70 | days | |
| All-cause Mortality at 1-year After Randomisation | Fluid Restriction Group | 385 | Participants | ||
| All-cause Mortality at 1-year After Randomisation | Standard-care | 383 | Participants | ||
| Health-related Quality of Life 1 Year After Randomisation | Fluid Restriction Group | 0 | Inter-Quartile Range 0 to 0.82 | EQ-5D-5L index values | |
| Health-related Quality of Life 1 Year After Randomisation | Standard-care | 0 | Inter-Quartile Range 0 to 0.81 | EQ-5D-5L index values | |
| Cognitive Function 1-year After Randomisation | Fluid Restriction Group | 0 | Inter-Quartile Range 0 to 22 | Units on a scale | |
| Cognitive Function 1-year After Randomisation | Standard-care | 0 | Inter-Quartile Range 0 to 22 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03668236/results